Nicholas Holowko Stock Analyst Profile - UBS Research Coverage - Stocknear

Nicholas Holowko

Stock Analyst at UBS

(3.19)
# 2886
Out of 5,506 analysts
20
Total ratings
Success rate
Average return

16 Stocks

Name Action PT Current % Upside Ratings Updated
SNV Synovus Financial
Downgrades: Neutral
63 56
48.66 15.08% 2 Sep 2, 2025
INCY Incyte
Maintains: Neutral
62 68
86.85 -21.7% 3 Jul 30, 2025
CMA Comerica
Upgrades: Neutral
59
70.54 -16.36% 2 Apr 10, 2025
ZION Zions Bancorp
Assumes: Neutral
64
56.93 12.42% 1 Dec 17, 2024
BPOP Popular
Assumes: Neutral
104
125.93 -17.41% 1 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
12
12.03 -4.41% 1 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
35
31.89 9.75% 1 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
32
26.41 21.17% 1 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
48 51
51.23 -0.45% 1 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
100 112
106.51 5.15% 1 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
157
130.4 20.4% 1 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
76
59.6 27.52% 1 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
115
86.75 32.56% 1 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
132
99.37 32.84% 1 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
2700
1762.68 53.18% 1 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
20 25
22.57 10.77% 1 Dec 17, 2024